PubMed · 8089306
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
L M Field. 1994. Facial flaps.. https://doi.org/10.1016/s0190-9622(08)81749-5
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Explore the source record for details and available documents.
In 1989, the Acoustic Neuroma Association established a multisurgeon, multi-institutional registry to collect data related to the treatment of patients with acoustic neuroma. This report analyzes information from the 1579 surgically treated patients who were entered in the registry between January 1, 1989, and February 28, 1994.
Most options for rejuvenation of the lower face use soft-tissue fillers that augment the appropriate sites. Each of these options has associated risks and benefits. The U.S. Food and Drug Administration recently approved the use of expanded polytetrafluoroethylene (E-PTFE) as a soft-tissue filler in the face. From January 1991 through December 1993, the authors used E-PTFE soft-tissue patches for lower facial augmentation in 41 patients at 115 implant sites. Postsurgical follow-up has ranged from 2.5 to 4.5 years; during this time, complications have occurred in 4 patients. One implant had to be removed because of a seroma (1 patient), 4 implants required further secondary augmentation (2 patients), and 1 implant required revision because of malposition (1 patient). There have been no cases of implant infection, extrusion, long-term inflammation, or capsule formation. In this article, the authors review the technical aspects of E-PTFE use and discuss issues relating to the long-term efficacy of this new option for soft-tissue augmentation. The technique is also compared with other options for rejuvenation of the lower face.